Constantine Davides
Stock Analyst at Citizens JMP
(0.12)
# 4,722
Out of 5,073 analysts
170
Total ratings
36.9%
Success rate
-11.6%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Reiterated: Buy | $31 → $33 | $28.44 | +16.03% | 9 | Sep 8, 2026 | |
| NRC NRC Health | Reiterated: Buy | $23 → $26 | $20.31 | +28.02% | 2 | Jul 29, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $21 → $27 | $19.66 | +37.33% | 3 | Jul 20, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $122 → $111 | $97.88 | +13.40% | 9 | Jun 1, 2026 | |
| USPH U.S. Physical Therapy | Reiterated: Buy | $113 → $98 | $86.28 | +13.58% | 6 | May 8, 2026 | |
| ADUS Addus HomeCare | Reiterated: Buy | $150 → $142 | $117.95 | +20.39% | 8 | May 6, 2026 | |
| OPCH Option Care Health | Reiterated: Buy | $38 → $32 | $31.29 | +2.27% | 17 | Apr 30, 2026 | |
| AMN AMN Healthcare Services | Reiterated: Buy | $22 → $24 | $43.01 | -44.20% | 18 | Feb 23, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $48 → $34 | $28.84 | +17.89% | 3 | Feb 18, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $11 → $10 | $4.83 | +107.04% | 14 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $24 | $9.37 | +156.14% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $31 | $22.47 | +37.96% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.18 | n/a | 7 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $90.99 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $33.51 | n/a | 6 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $1.25 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $1.43 | n/a | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $2.91 | n/a | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $27.32 | n/a | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $20.91 | n/a | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.25 | $1.51 | n/a | 2 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.5 | $1.77 | n/a | 1 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.1664 | n/a | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $1.97 | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $33 | $0.5252 | n/a | 3 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $0.42 | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $8 | $1.26 | n/a | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.25 | $0.8925 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.3 | $0.4878 | n/a | 1 | Aug 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.415 | n/a | 1 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $62.07 | n/a | 1 | Sep 27, 2011 |
Progyny
Sep 8, 2026
Reiterated: Buy
Price Target: $31 → $33
Current: $28.44
Upside: +16.03%
NRC Health
Jul 29, 2026
Reiterated: Buy
Price Target: $23 → $26
Current: $20.31
Upside: +28.02%
Omada Health
Jul 20, 2026
Reiterated: Buy
Price Target: $21 → $27
Current: $19.66
Upside: +37.33%
HealthEquity
Jun 1, 2026
Reiterated: Buy
Price Target: $122 → $111
Current: $97.88
Upside: +13.40%
U.S. Physical Therapy
May 8, 2026
Reiterated: Buy
Price Target: $113 → $98
Current: $86.28
Upside: +13.58%
Addus HomeCare
May 6, 2026
Reiterated: Buy
Price Target: $150 → $142
Current: $117.95
Upside: +20.39%
Option Care Health
Apr 30, 2026
Reiterated: Buy
Price Target: $38 → $32
Current: $31.29
Upside: +2.27%
AMN Healthcare Services
Feb 23, 2026
Reiterated: Buy
Price Target: $22 → $24
Current: $43.01
Upside: -44.20%
Waystar Holding
Feb 18, 2026
Reiterated: Buy
Price Target: $48 → $34
Current: $28.84
Upside: +17.89%
Evolent Health
Jan 6, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $4.83
Upside: +107.04%
Nov 7, 2025
Reiterated: Buy
Price Target: $23 → $24
Current: $9.37
Upside: +156.14%
Nov 7, 2025
Reiterated: Buy
Price Target: $30 → $31
Current: $22.47
Upside: +37.96%
May 6, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.18
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $90.99
Upside: n/a
Feb 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $33.51
Upside: n/a
May 25, 2023
Initiated Coverage: Buy
Price Target: $18
Current: $1.25
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $125
Current: $1.43
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $19
Current: $2.91
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $15
Current: $27.32
Upside: n/a
May 10, 2023
Reiterated: Buy
Price Target: $23
Current: $20.91
Upside: n/a
Apr 18, 2023
Reiterated: Buy
Price Target: $5.25
Current: $1.51
Upside: n/a
Mar 30, 2023
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Mar 20, 2023
Initiated Coverage: Buy
Price Target: $8.5
Current: $1.77
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $6
Current: $0.1664
Upside: n/a
Feb 15, 2023
Reiterated: Buy
Price Target: $15
Current: $1.97
Upside: n/a
Dec 30, 2022
Reiterated: Buy
Price Target: $50 → $33
Current: $0.5252
Upside: n/a
Oct 18, 2022
Initiated Coverage: Buy
Price Target: $68
Current: $0.42
Upside: n/a
Sep 28, 2022
Reiterated: Buy
Price Target: $14 → $8
Current: $1.26
Upside: n/a
Sep 23, 2022
Reiterated: Buy
Price Target: $4.25
Current: $0.8925
Upside: n/a
Aug 18, 2022
Reiterated: Buy
Price Target: $2.3
Current: $0.4878
Upside: n/a
Mar 14, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $0.415
Upside: n/a
Sep 27, 2011
Initiated Coverage: Buy
Price Target: $41
Current: $62.07
Upside: n/a